Get the Stockscreener App
44.50
1.42%
-0.64
Septerna Inc stock is traded at $44.50, with a volume of 630.34K.
It is down -1.42% in the last 24 hours and up +28.84% over the past month.
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
See More
Previous Close:
$45.14
Open:
$45
24h Volume:
630.34K
Relative Volume:
1.44
Market Cap:
$2.08B
Revenue:
$45.95M
Net Income/Loss:
$-48.88M
P/E Ratio:
-39.99
EPS:
-1.1129
Net Cash Flow:
$109.67M
1W Performance:
+14.60%
1M Performance:
+28.84%
6M Performance:
+61.82%
1Y Performance:
+280.99%
1-Day Range:
$43.64
$46.50
1-Week Range:
$38.05
$51.10
52-Week Range:
$10.74
$51.10
Septerna Inc Stock (SEPN) Company Profile
Name
Septerna Inc
Sector
Industry
Phone
650-338-3533
Address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Compare SEPN vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
44.50 | 2.25B | 45.95M | -48.88M | 109.67M | -1.1129 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Initiated | Raymond James | Strong Buy |
| Dec-15-25 | Initiated | Truist | Buy |
| Nov-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jun-23-25 | Initiated | H.C. Wainwright | Buy |
| Feb-18-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-19-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-19-24 | Initiated | JP Morgan | Overweight |
| Nov-19-24 | Initiated | TD Cowen | Buy |
| Nov-19-24 | Initiated | Wells Fargo | Overweight |
View All
Septerna Inc Stock (SEPN) Latest News
Ra Capital Management sells $63.45m in Septerna stock By Investing.com - Investing.com Nigeria
Septerna(SEPN.US) 10% Shareholder Sells US$7.4 Million in Common Stock - Moomoo
Third Rock Ventures V, L.P. director sells $7.4m Septerna shares - Investing.com South Africa
RA Capital Management Offloads 1.49 Million Septerna Shares at $42.50 Each - Kalkine Media
Septerna (SEPN): RA Capital funds disclose sale of 1.49M common shares - Stock Titan
Form 4: Third Rock Ventures reports acquisition/exercise transactions in SEPN - Stock Titan
RA Capital group (SEPN) discloses 11.8% Septerna stake and major block sales - Stock Titan
HC Wainwright Predicts Septerna's Q3 Earnings (NASDAQ:SEPN) - MarketBeat
Driehaus Capital Management (SEPN) discloses 4.43M-share Septerna stake in 13G/A - Stock Titan
Septerna (NASDAQ:SEPN) COO Elizabeth Bhatt Sells 25,000 Shares of Stock - MarketBeat
Septerna president & COO Elizabeth Bhatt disposes of $1.1m in stock - Investing.com Australia
Septerna (SEPN) President & COO exercises 25,000 options and sells shares under 10b5-1 plan - Stock Titan
Septerna (NASDAQ:SEPN) Trading Down 6.1%Here's Why - MarketBeat
JonesTrading Forecasts Strong Price Appreciation for Septerna (NASDAQ:SEPN) Stock - MarketBeat
Wall Street Analysts Are Bullish on Top NA Picks - The Globe and Mail
Stifel Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $49 - Moomoo
Septerna, Inc. SEC Filing (Aug 12, 2026) - Stock Titan
SEPN (SEPN) plans NASDAQ sale of 746,500 shares worth $35.97M - Stock Titan
Does Septerna (SEPN) Pair Narrowing Losses With A Cash Runway That Truly Supports Its Pipeline Strategy? - simplywall.st
Septerna Inc stock hits all-time high at 50.0 USD By Investing.com - Investing.com Canada
Septerna (NASDAQ:SEPN) Sees Unusually-High Trading Volume on Analyst Upgrade - MarketBeat
SEPN Maintained by Wells Fargo -- Price Target Raised to $50 - GuruFocus
H.C. Wainwright raises Septerna stock price target to $60 on SEP-479 progress - Investing.com
A Quick Look at Today's Ratings for Septerna(SEPN.US), With a Forecast Between $49 to $60 - Moomoo
Septerna (NASDAQ:SEPN) Price Target Raised to $50.00 at Wells Fargo & Company - MarketBeat
Septerna (NASDAQ:SEPN) Price Target Raised to $60.00 - MarketBeat
SEPN Maintained by HC Wainwright & Co. -- Price Target Raised to $60 - GuruFocus
Septerna Shares (SEPN) Surge 23% Following Positive SEP-479 Signal, Exceeding Analyst Predictions - TechStock²
Stifel raises Septerna stock price target to $49 on SEP-479 outlook - Investing.com UK
Septerna, Inc. Stock 12‑Month Price Target Raised to $47, Implies 21% Upside - TradingView
Seer (SEPN) insiders plan sale of 29,000 shares after option exercise - Stock Titan
SEPN Maintains by Guggenheim -- Price Target Raised to $51.00 - GuruFocus
Raymond James Maintains Septerna(SEPN.US) With Buy Rating, Cuts Target Price to $49 - Moomoo
Septerna (NASDAQ:SEPN) Stock Price Up 9% Following Earnings Beat - MarketBeat
Stifel raises Septerna stock price target to $49 on SEP-479 outlook By Investing.com - Investing.com India
Guggenheim raises Septerna stock price target to $51 on pipeline progress - Investing.com
SEPN SWOT Analysis: Key Insights from 10-Q Filing - GuruFocus
Septerna, Inc. (SEPN) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Septerna (NASDAQ:SEPN) Releases Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
Septerna Q2 2026 Results: Revenue Surges to $26.7M on Novo Nordisk Collaboration - scanx.trade
Septerna Q2 Loss Narrows, Revenue Rises - marketscreener.com
Earnings Flash (SEPN) Septerna Posts Q2 Loss Per Share $0.29, vs. FactSet Est of $0.43 Loss - marketscreener.com
Septerna, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings Flash (SEPN) Septerna, Inc. Reports Q2 Revenue $26.7M, vs. FactSet Est of $19.2M - marketscreener.com
Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results - The Manila Times
Septerna Q2 revenue beats analyst estimates, driven by Novo Nordisk partnership - TradingView
Septerna (SEPN) boosts collaboration revenue and extends cash runway into 2029 - Stock Titan
Septerna, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Septerna (NASDAQ:SEPN) Hits New 1-Year HighStill a Buy? - MarketBeat
Price to book forward of Septerna, Inc. – NASDAQ:SEPN - TradingView
Septerna Inc (SEPN) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Septerna Inc Stock (SEPN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):